Market overview
The global extracorporeal membrane oxygenation market is worth USD 738 mn in 2026 and is forecast to reach USD 1.3 bn by 2036, growing at a 5.5% CAGR. United States is the largest country market and Circuits and oxygenators is the largest by product segment.
| Scope | Extracorporeal life-support systems that oxygenate blood outside the body for severe lung and heart failure: ECMO consoles, pumps, oxygenators and circuit kits. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 700 mn |
| Value 2026 | USD 738 mn |
| Value 2036 | USD 1.3 bn |
| CAGR 2026-2036 | 5.5% |
| Volume 2026 | 54.6 thousand circuits |
| Volume 2036 | 88.7 thousand circuits |
| Average price 2026 | USD 13,530 per circuit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Extracorporeal Membrane Oxygenation market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 738.5 mn |
| 2027 | USD 779.1 mn |
| 2028 | USD 822.0 mn |
| 2029 | USD 867.2 mn |
| 2030 | USD 914.9 mn |
| 2031 | USD 965.2 mn |
| 2032 | USD 1.02 bn |
| 2033 | USD 1.07 bn |
| 2034 | USD 1.13 bn |
| 2035 | USD 1.20 bn |
| 2036 | USD 1.26 bn |
Extracorporeal Membrane Oxygenation market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Circuits and oxygenators | 50.0% | 50.1% | USD 369 mn | 5.5% |
| Consoles and pumps | 28.0% | 26.8% | USD 207 mn | 5.0% |
| Cannulae and accessories | 22.0% | 23.1% | USD 162 mn | 6.0% |
By support type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Respiratory | 44.0% | 42.7% | USD 325 mn | 5.2% |
| Cardiac | 36.0% | 34.9% | USD 266 mn | 5.2% |
| Extracorporeal CPR | 20.0% | 22.4% | USD 148 mn | 6.7% |
By patient
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adults | 70.0% | 71.0% | USD 517 mn | 5.7% |
| Paediatric | 18.0% | 17.4% | USD 133 mn | 5.2% |
| Neonatal | 12.0% | 11.6% | USD 89 mn | 5.2% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 64.0% | 60.0% | USD 473 mn | 4.8% |
| Specialty ECMO centres | 22.0% | 24.0% | USD 162 mn | 6.4% |
| Transport and mobile services | 14.0% | 16.0% | USD 103 mn | 6.9% |
By support duration
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Short-term | 38.0% | 34.0% | USD 281 mn | 4.3% |
| Medium-term | 38.0% | 38.0% | USD 281 mn | 5.5% |
| Prolonged | 24.0% | 28.0% | USD 177 mn | 7.1% |
Top 25 countries for extracorporeal membrane oxygenation by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.0% of 2026 revenue and the 25 countries below together hold 97.3%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 266 mn | 36.0% | USD 436 mn | 5.1% |
| 2 | Germany | USD 81 mn | 11.0% | USD 134 mn | 5.1% |
| 3 | China | USD 74 mn | 10.0% | USD 160 mn | 8.1% |
| 4 | Japan | USD 59 mn | 8.0% | USD 92 mn | 4.5% |
| 5 | France | USD 44 mn | 6.0% | USD 73 mn | 5.1% |
| 6 | United Kingdom | USD 37 mn | 5.0% | USD 61 mn | 5.1% |
| 7 | Italy | USD 30 mn | 4.0% | USD 48 mn | 5.0% |
| 8 | South Korea | USD 26 mn | 3.5% | USD 47 mn | 6.1% |
| 9 | Spain | USD 22 mn | 3.0% | USD 37 mn | 5.1% |
| 10 | Brazil | USD 18 mn | 2.5% | USD 33 mn | 5.9% |
| 11 | Canada | USD 8.2 mn | 1.1% | USD 13 mn | 4.8% |
| 12 | Australia | USD 6.3 mn | 0.9% | USD 10 mn | 4.9% |
| 13 | India | USD 5.5 mn | 0.7% | USD 13 mn | 9.2% |
| 14 | Netherlands | USD 4.5 mn | 0.6% | USD 7.3 mn | 5.0% |
| 15 | Switzerland | USD 4.5 mn | 0.6% | USD 7.3 mn | 5.0% |
| 16 | Turkey | USD 4.5 mn | 0.6% | USD 9.1 mn | 7.3% |
| 17 | Belgium | USD 3.6 mn | 0.5% | USD 5.8 mn | 4.8% |
| 18 | Saudi Arabia | USD 3.6 mn | 0.5% | USD 7.3 mn | 7.3% |
| 19 | Mexico | USD 3.6 mn | 0.5% | USD 7.3 mn | 7.3% |
| 20 | Taiwan | USD 3.6 mn | 0.5% | USD 5.8 mn | 4.8% |
| 21 | Austria | USD 2.7 mn | 0.4% | USD 4.4 mn | 4.9% |
| 22 | Sweden | USD 2.7 mn | 0.4% | USD 4.4 mn | 4.9% |
| 23 | Poland | USD 2.7 mn | 0.4% | USD 4.4 mn | 4.9% |
| 24 | Israel | USD 2.7 mn | 0.4% | USD 4.4 mn | 4.9% |
| 25 | Russia | USD 2.7 mn | 0.4% | USD 4.4 mn | 4.9% |
| Rest of world | USD 20 mn | 2.6% | USD 33 mn | 5.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Getinge
- Medtronic
- LivaNova
- Fresenius Medical Care
Group 2: Regional and specialist players
- Terumo
- Nipro
- Eurosets
- Spectrum Medical
- Cardiac Assist
- Chalice Medical
Group 3: Emerging and niche players
- Abiomed
- Xenios
- Hemovent
- Lifebridge Medizintechnik
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the extracorporeal membrane oxygenation market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.5% is calculated from the resulting values.
The market is divided by product, by support type, by patient, by end user, by support duration. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the extracorporeal membrane oxygenation market?
The global extracorporeal membrane oxygenation market is estimated at USD 700 mn in 2025 and USD 738 mn in 2026.
How fast will the extracorporeal membrane oxygenation market grow?
It is forecast to reach USD 1.3 bn by 2036, a compound annual growth rate of 5.5% from 2026, an increase of USD 523 mn.
Which country is the largest market for extracorporeal membrane oxygenation?
United States is the largest market by revenue at USD 266 mn in 2026, 36.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.1% a year from 2026 to 2036.
Which extracorporeal membrane oxygenation segment is largest?
In the by product split, Circuits and oxygenators is the largest segment with 50.0% of 2026 revenue.
Who are the leading extracorporeal membrane oxygenation companies?
Global leaders include Getinge, Medtronic, LivaNova, Fresenius Medical Care.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Fluid Bed DryerUSD 742 mn · 6.0% CAGR
- Nasal Congestion Treatment DevicesUSD 735 mn · 4.8% CAGR
- Cervical Spacer SystemsUSD 746 mn · 6.0% CAGR
- 1-Step RT-PCR KitsUSD 728 mn · 5.0% CAGR
- Patient-Specific Surgical Implant DesignUSD 722 mn · 10.5% CAGR
- Smart InhalerUSD 713 mn · 15.0% CAGR
- AI-Powered Behavioral TherapyUSD 768 mn · 17.0% CAGR
- Precision Transplant MedicineUSD 770 mn · 9.5% CAGR
← Extracorporeal Membrane Oxygenation Machine Fat Modular Nutrition →